BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 32476780)

  • 1. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis
    Qiu LW; Liu YF; Cao XQ; Wang Y; Cui XH; Ye X; Huang SW; Xie HJ; Zhang HJ
    World J Gastroenterol; 2020 May; 26(18):2126-2137. PubMed ID: 32476780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
    Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
    Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgelin-2 contributes to proliferation and progression of hepatocellular carcinoma via regulating Annexin A2.
    Shi J; Ren M; She X; Zhang Z; Zhao Y; Han Y; Lu D; Lyu L
    Biochem Biophys Res Commun; 2020 Mar; 523(3):632-638. PubMed ID: 31941608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis.
    Tang L; Liu JX; Zhang ZJ; Xu CZ; Zhang XN; Huang WR; Zhou DH; Wang RR; Chen XD; Xiao MB; Qu LS; Lu CH
    Pathol Res Pract; 2019 Jun; 215(6):152386. PubMed ID: 30935762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma.
    Lou Y; Yu Y; Xu X; Zhou S; Shen H; Fan T; Wu D; Yin J; Li G
    J Cell Mol Med; 2019 Mar; 23(3):1873-1884. PubMed ID: 30588744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma.
    Xia Y; Brown ZJ; Huang H; Tsung A
    Cancer Med; 2021 Sep; 10(18):6374-6383. PubMed ID: 34390203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
    Kohli S; Bhardwaj A; Kumari R; Das S
    Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures.
    Shi H; Xiao L; Duan W; He H; Ma L; Da M; Duan Y; Wang Q; Wu H; Song X; Hou Y
    Micron; 2016 Jun; 85():26-33. PubMed ID: 27060670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma.
    Yu H; Zhu X; Lin H; Pan H; Zhao F; Zhu M; Sun L; Chai W; Yao M; Yan M
    Aging (Albany NY); 2020 Jun; 12(12):12234-12250. PubMed ID: 32564007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
    Chen H; Li Y; Xiao SY; Guo J
    BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.
    Zhong D; Shi Y; Ma W; Liang Y; Liu H; Qin Y; Zhang L; Yang Q; Huang X; Lu Y; Shang J
    Immun Inflamm Dis; 2024 May; 12(5):e1264. PubMed ID: 38780041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells.
    Zhang W; Zhao P; Xu XL; Cai L; Song ZS; Cao DY; Tao KS; Zhou WP; Chen ZN; Dou KF
    PLoS One; 2013; 8(8):e67268. PubMed ID: 23950866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
    Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
    Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.
    Keenan BP; Fong L; Kelley RK
    J Immunother Cancer; 2019 Oct; 7(1):267. PubMed ID: 31627733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma.
    Wu ZH; Yang DL; Wang L; Liu J
    Front Immunol; 2021; 12():793343. PubMed ID: 34925377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis.
    Herrera-López EE; Guerrero-Escalera D; Aguirre-Maldonado I; López-Hernández A; Montero H; Gutiérrez-Nava MA; Del Pozo-Yauner L; Arellanes-Robledo J; Camacho J; Pérez-Carreón JI
    Sci Rep; 2023 Apr; 13(1):6948. PubMed ID: 37117324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.
    Meylan M; Petitprez F; Lacroix L; Di Tommaso L; Roncalli M; Bougoüin A; Laurent A; Amaddeo G; Sommacale D; Regnault H; Derman J; Charpy C; Lafdil F; Pawlotsky JM; Sautès-Fridman C; Fridman WH; Calderaro J
    Clin Cancer Res; 2020 Aug; 26(16):4381-4389. PubMed ID: 32269054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
    J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.